Nat-Anastrozole 1 mg (Anastrozole TABLET) 1 MG

Anastrozole 1 mg tablets are a non-steroidal aromatase inhibitor used to manage hormone-related conditions. This prescription medication is available in a 30-tablet pack from Natco Pharma (Canada) Inc.

Strength

1 MG

Pack Size

Manufacturer / TM Owner

NATCO PHARMA (CANADA) INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Anastrozole is primarily used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by reducing estrogen levels in the body, which can help slow the growth of certain types of breast cancer. Anastrozole may also be prescribed for other hormone-sensitive conditions as determined by a healthcare provider.

Side Effects

Common effects of Anastrozole may include hot flashes, joint pain, and fatigue. Some users may experience mood changes or weakness. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Anastrozole should be used with caution in individuals with a history of osteoporosis or liver disease. It is important to follow the prescribed dosage and schedule. Pregnant women should avoid handling crushed or broken tablets due to potential risks.

Avoid Interactions

Anastrozole may interact with other medications, including estrogen-containing therapies and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.

Frequently Asked Questions

Anastrozole is used to treat hormone receptor-positive breast cancer in postmenopausal women by reducing estrogen levels.

Anastrozole is typically taken orally, once daily, with or without food. Follow the specific instructions provided by your healthcare provider.

Common side effects may include hot flashes, joint pain, and fatigue. Always consult a healthcare provider for personalized advice.

Anastrozole may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

Anastrozole is not recommended for use during pregnancy. Pregnant women should avoid handling crushed or broken tablets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.